Your browser doesn't support javascript.
loading
Effect of simvastatin on monocyte CX3CR1 expression in patients with acute coronary syndrome / 南方医科大学学报
Journal of Southern Medical University ; (12): 475-477, 2008.
Article Dans Chinois | WPRIM | ID: wpr-293348
ABSTRACT
<p><b>OBJECTIVE</b>To observe the effect of simvastatin on expression of CX3CR1 in the monocytes in patients with acute coronary syndrome and investigate the non-lipid mechanisms of statins against atherosclerosis.</p><p><b>METHODS</b>The expression of CX3CR1 in the monocytes was measured by quantitative real-time RT-PCR in 63 patients with acute coronary syndrome confirmed by coronary arteriography after treatment with simvastatin at 10(-7) approximately 10(-5) mol/L for 4, 8 and 12 h, respectively.</p><p><b>RESULTS</b>CX3CR1 expression in the monocytes treated with different concentrations of simvastatin was significantly lower than that in the control cells (P<0.05), and the expression in the cells treated with the agent for different time lengths was also significantly lower than that in the control cells (P<0.01).</p><p><b>CONCLUSION</b>Simvastatin can reduce CX3CR1 expression in the monocytes of the patients with acute coronary syndrome in a concentration- and time-dependent manner, so as to reduce the inflammation and stabilize the vascular plaques.</p>
Sujets)
Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) Sujet Principal: Sang / Monocytes / Expression des gènes / Simvastatine / Récepteurs aux chimiokines / RT-PCR / Utilisations thérapeutiques / Traitement médicamenteux / Syndrome coronarien aigu / Récepteur-1 de la chimiokine CX3C Limites du sujet: Femelle / Humains / Mâle langue: Chinois Texte intégral: Journal of Southern Medical University Année: 2008 Type: Article

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) Sujet Principal: Sang / Monocytes / Expression des gènes / Simvastatine / Récepteurs aux chimiokines / RT-PCR / Utilisations thérapeutiques / Traitement médicamenteux / Syndrome coronarien aigu / Récepteur-1 de la chimiokine CX3C Limites du sujet: Femelle / Humains / Mâle langue: Chinois Texte intégral: Journal of Southern Medical University Année: 2008 Type: Article